CannMed

04/22/2026

NEW CannMed Coffee Talk Podcast, we discuss AI and Machine Learning in Medical Cannabis.

Dr. Hemant Kumar Bid serves as Program Director for the Morehouse School of Medicine. He has become deeply engaged with Artificial Intelligence and Machine Learning through his academic, clinical, and program development work.

During our conversation, we discuss:

- How AI and machine learning are accelerating drug discovery, enabling personalized treatment, and analyzing complex genomic and clinical data.
- Why the accuracy of AI predictions depends entirely on data quality fed into the models, making standardization, diverse representation, and clean datasets critical for success
- Major challenges that need to be overcome before AI and ML can truely transform medical cannabis treatment.

Watch now: https://hubs.li/Q04d4_C60

Thanks to Tikun Olam USA for sponsoring!

04/22/2026

NEW CANNMED COFFEE TALK PODCAST

Dr. Hemant Kumar Bid serves as Program Director for the Morehouse School of Medicine, and has become deeply engaged with Artificial Intelligence and Machine Learning through his academic, clinical, and program development work.

During our conversation we discuss:

How AI and machine learning are accelerating drug discovery, enabling personalized treatment, and analyzing complex genomic and clinical data.

Why the accuracy of AI predictions depends entirely on data quality fed into the models, making standardization, diverse representation, and clean datasets critical for success

Major challenges that need to be overcome before AI and ML can truely transform medical cannabis treatment.

Watch and listen on YouTube and all podcast apps!

Thanks to for sponsoring!

02/25/2026

NEW CannMed Coffee Talk, we discuss Discovering Non-Grandular Trichomes Secrete Salts!��Dr. Zamir Punja is a Professor of Plant Biotechnology at in Canada. His research interests include the etiology and management of plant diseases and the applications of plant biotechnology for disease management. Since 2018, his work has focused on cannabis, identifying and describing a range of previously unreported pathogens affecting the crop and evaluating various methods for disease management.

Zamir is CannMed regular, having presented at 5 previous events. His presentations are always a highlight of the event because they often feature stunning electron microscope images showing plant structures and pathogens up close. In fact, his CannMed 22 presentation about glandular trichomes has gotten more than 300,000 views on our YouTube page, making it the most viewed CannMed presentation.

Zamir will again present at CannMed 26, this time about non-glandular trichomes in a presentation titled “Non-glandular trichomes in cannabis plants can secrete salts”.

During our conversation, we discuss:�
⦾ Non-glandular trichomes: What they are and what they do.
⦾ How leaf spots, initially mistaken for disease, led to the finding that cannabis secretes excess fertilizer salts through these trichomes.
⦾ Theories on why the plant would develop the ability to actively excrete excess salts.
⦾ Practical guidance for cultivators on how to distinguish overfertilization from disease.
⦾ Future research directions — comparing salt-tolerant vs. non-tolerant strains under varying salinity levels and exploring whether this mechanism explains cannabis’s resilience in drought-prone, high-salt environments.
�Watch Now: Link 🔗 in Bio�
Thanks to This Episode’s Sponsor:

02/11/2026

NEW CannMed Coffee Talk, we discuss Demystifying Cannabinoid Hyperemesis Syndrome!

Dr. Codi Petersen is a pediatric pharmacist with over a decade of experience specializing in acute care and pediatric emergency medicine. He currently serves as a clinical pharmacist at Rady’s Children’s Health of Orange County, where he works night shifts in the Emergency Department and applies his expertise to optimize medication safety and therapeutic outcomes in children. Beyond the hospital, Codi is deeply committed to education and mentorship. He is an Associate Clinical Professor at the University of California, Irvine, where he teaches cannabis pharmacology and therapeutics, and a guest lecturer at OCEMT, instructing paramedics and firefighters in applied pharmacology.

He is also an active researcher on Cannabinoid Hyperemesis Syndrome (CHS), having led one of the largest patient surveys on the condition to date. At CannMed 26, Codi will share the results of that study in a presentation titled, “Through the Eyes of a Patient: Integrating Story and Science to Demystify CHS”. 

During our conversation, we discuss:

⦾ Defining CHS and explaining why it is difficult to research 
⦾ Cannabis use patterns among CHS sufferers 
⦾ Whether contaminants and pesticides play a role in developing CHS 
⦾ The prodromal phase and early warning signs of CHS 
⦾ Sex-based differences in CHS patients 
⦾ Understanding the biological mechanisms behind the development of CHS 
⦾ And more!

Watch Now: Link 🔗 in Bio

Thanks to This Episode’s Sponsor:

02/06/2026

Cannabinoid Hyperemesis Syndrome (CHS) remains one of cannabis medicine’s most puzzling challenges, but new patient data is changing how we understand and recognize it.

Join Dr. Codi Peterson ( ), Chief Science Officer at and pediatric pharmacist with over a decade of acute care expertise, as he presents groundbreaking findings from a survey of 1,134 CHS patients. “Through the Eyes of a Patient: Integrating Story and Science to Demystify CHS” bridges the gap between clinical research and lived experience.

Learning Objectives:

⦾ Identify the key signs, symptoms, and varied presentations of Cannabinoid Hyperemesis Syndrome
⦾ Explain the current understanding of CHS and how recent patient survey data expands that knowledge
⦾ Formulate focused assessment questions and communication strategies for patients afflicted with CHS

View Codi’s Abstract & Bio: Link 🔗 in Bio!

02/03/2026

The CannMed 26 schedule is here!

This year’s summit features 20 expert-curated presentations, a full-day Medical Practicum for clinicians, Cultivation and Regulatory workshops, networking events, poster sessions and more.

Early bird pricing through February 20th. Save up to $300!

View Schedule & Register: Link 🔗 in Bio

01/28/2026

NEW CannMed Coffee Talk, we discuss Preventing Opioid Overdose with Cannabinoids!

Dr. Beth Wiese is the Research and Overdose Prevention Coordinator for , a non-profit organization that aids unhoused, drug-using, survivor & s*x worker populations by providing direct services including crisis response, system advocacy, wound care, job placement, medication-assisted treatment (MAT), and creative community resources for mental health. Her work aims to influence future drug policy with novel evidence-based research that also advocates and empowers people who use drugs to feel safe and prevent fatal overdose

At CannMed 26, Beth will present “Cannabidiol to Mitigate Opioid Induced Respiratory Depression”. During our conversation, we discuss:

⦾ What causes Opioid Induced Respiratory Depression and how cannabinoids play a role
⦾ How CBD can be used in combination with Naloxone to reduce withdrawal-related side effects
⦾ How Beth’s research can be applied in real-world scenarios

Watch Now: Link 🔗in Bio

Thanks to This Episode’s Sponsor:

01/14/2026

NEW CannMed Coffee Talk, we discuss Combining CBG and Chemotherapy to Treat Pancreatic Cancer!

Dr. Mandip Sachdeva is currently a Professor and Section leader, Pharmaceutics at College of Pharmacy at Florida A & M University ( ), Tallahassee, Florida. Over his career, Mandip has delivered more than 250 plenaries, keynote and invited talks in international events and meetings and produced more than 190 original publications.His research interests include cancer drug delivery, 3D-printing of tumor cells, and formulating and developing targeted nanoparticles, exosomes and cann*binoids for cancer treatments.

During our conversation, Mandip previews his CannMed 26 oral presentation titled, “Cannabigerol Potentiates Chemotherapy through Multi-Modal Tumor Suppression in Pancreatic Cancer“, which includes insights into his research on using cann*binoids (particularly CBG) to treat pancreatic cancer—one of the most difficult cancers to treat.

We cover: 
* The process Mandip’s team used to determine CBG had the best anti-cancer effects against pancreatic cancer 
* CBG’s mechanism of action, which targets multiple pathways related to immune regulation, cell death, and tumor migration control
* Why cann*binoids are best used as adjuncts to chemotherapy and not as a standalone treatment 
* Higher doses of CBG (up to 100 mg/kg) were non-toxic and further extended survival when combined with reduced chemo doses
* Future research directions, including new combinations of cann*binoids and chemotherapy as well as new formulations for better absorption and bioavailability 

Watch Now: Link 🔗 in Bio!

Thanks to This Episode’s Sponsor: .com_

01/08/2026

Canned 26 Innovation & Collaboration Summit tickets are now available! Join us June 15-18 at the Hyatt Regency Lake Tahoe Resort, Spa and Casino for four days of cutting-edge c*nnabis research and industry collaboration.

Early Bird Pricing is available now through February 20th and offers savings of up to $300 on your ticket package. We’re also excited to offer an exclusive cultivator package with , including elite fertilizers valued at over $11,000, cultivation consultations, and genome sequencing from .genomics

Whether you’re a researcher, clinician, cultivator, or industry professional, we have package options designed to meet your needs. Review all available ticket packages and secure your spot at the premier c*nnabis science and innovation event.

Register today & Link in Bio and take advantage of early bird savings before February 20th.

01/06/2026